212 related articles for article (PubMed ID: 33783856)
21. Retrospective analysis of long-term lipid apheresis at a single center.
Koziolek MJ; Hennig U; Zapf A; Bramlage C; Grupp C; Armstrong VW; Strutz F; Müller GA
Ther Apher Dial; 2010 Apr; 14(2):143-52. PubMed ID: 20438535
[TBL] [Abstract][Full Text] [Related]
22. A case report of double filtration plasmapheresis in an acute episode of multiple sclerosis.
Ramunni A; De Robertis F; Brescia P; Saliani MT; Amoruso M; Prontera M; Dimonte E; Trojano M; Coratelli P
Ther Apher Dial; 2008 Jun; 12(3):250-4. PubMed ID: 18503704
[TBL] [Abstract][Full Text] [Related]
23. Double filtration plasmapheresis: Review of current clinical applications.
Hirano R; Namazuda K; Hirata N
Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
[TBL] [Abstract][Full Text] [Related]
24. Reducing Fibrinogen and Factor XIII Using Double-Filtration Plasmapheresis for Antibody-Mediated Rejection: Predictive Models.
Jouve T; Marlu R; Malvezzi P; Seyve L; Maurizi J; Carron PL; Polack B; Rostaing L
Blood Purif; 2018; 46(3):239-245. PubMed ID: 29972828
[TBL] [Abstract][Full Text] [Related]
25. Selective plasma exchange can reduce auto-antibodies in patients with bullous pemphigoid without affecting factor XIII and fibrinogen.
Nasu K; Hanafusa N; Nangaku M
J Clin Apher; 2017 Dec; 32(6):589-591. PubMed ID: 27709645
[TBL] [Abstract][Full Text] [Related]
26. Treatment of refractory myasthenia gravis by double-filtration plasmapheresis and rituximab: A case series of nine patients and literature review.
Bennani HN; Lagrange E; Noble J; Malvezzi P; Motte L; Chevallier E; Rostaing L; Jouve T
J Clin Apher; 2021 Jun; 36(3):348-363. PubMed ID: 33349954
[TBL] [Abstract][Full Text] [Related]
27. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
[TBL] [Abstract][Full Text] [Related]
28. Physiological role of plasma and its components and the clinical implications of different methods of apheresis: A narrative review.
Ahmadpoor P; Aglae C; Cariou S; Pambrun E; Renaud S; Garo F; Darmon R; Schultz C; Prelipcean C; Reboul P; Moranne O
Ther Apher Dial; 2021 Jun; 25(3):262-272. PubMed ID: 32710797
[TBL] [Abstract][Full Text] [Related]
29. [How to implement a complete apheresis program within a hemodialysis unit].
Maurizi-Balzan J; Jouve T; Naciri-Bennani H; Noble J; Tanoukhi K; Motte L; Malvezzi P; Rostaing L
Nephrol Ther; 2019 Nov; 15(6):439-447. PubMed ID: 31585841
[TBL] [Abstract][Full Text] [Related]
30. Comparison of three modalities of plasmapheresis on coagulation: Centrifugal, single-membrane filtration, and double-filtration plasmapheresis.
Marlu R; Naciri Bennani H; Seyve L; Noble J; Chevallier E; Motte L; Imerzoukene F; Bugnazet M; Christophe M; Malvezzi P; Jouve T; Rostaing L
J Clin Apher; 2021 Jun; 36(3):408-419. PubMed ID: 33506958
[TBL] [Abstract][Full Text] [Related]
31. Fibrinogen reduction and bleeding complications in plasma exchange, immunoadsorption and a combination of the two.
Zöllner S; Pablik E; Druml W; Derfler K; Rees A; Biesenbach P
Blood Purif; 2014; 38(2):160-6. PubMed ID: 25501972
[TBL] [Abstract][Full Text] [Related]
32. Influence of atorvastatin versus simvastatin on fibrinogen and other hemorheological parameters in patients with severe hypercholesterolemia treated with regular low-density lipoprotein immunoadsorption apheresis.
Otto C; Geiss HC; Donner MG; Parhofer KG; Schwandt P
Ther Apher; 2000 Jun; 4(3):244-8. PubMed ID: 10910028
[TBL] [Abstract][Full Text] [Related]
33. [Apheresis therapy in Guillain-Barré syndrome].
Nagayama H; Katayama Y
Nihon Rinsho; 2008 Jun; 66(6):1195-9. PubMed ID: 18540370
[TBL] [Abstract][Full Text] [Related]
34. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late-onset myasthenia gravis.
Liu JF; Wang WX; Xue J; Zhao CB; You HZ; Lu JH; Gu Y
Ther Apher Dial; 2010 Apr; 14(2):153-60. PubMed ID: 20438536
[TBL] [Abstract][Full Text] [Related]
35. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
[TBL] [Abstract][Full Text] [Related]
36. Double filtration plasmapheresis for children with different types of critical kidney diseases: a single-center retrospective cohort study.
Zhang Y; Xie Q; Chen Y; Yang J; Huang S; Deng L; Zhou J
Transl Pediatr; 2023 Mar; 12(3):354-363. PubMed ID: 37035407
[TBL] [Abstract][Full Text] [Related]
37. Effect of combined treatment with immunoadsorption and membrane filtration on plasma coagulation--Results of a randomized controlled crossover study.
Biesenbach P; Eskandary F; Ay C; Wiegele M; Derfler K; Schaden E; Haslacher H; Oberbauer R; Böhmig GA
J Clin Apher; 2016 Feb; 31(1):29-37. PubMed ID: 25919120
[TBL] [Abstract][Full Text] [Related]
38. Removal kinetics of antibodies against glutamic acid decarboxylase by various plasmapheresis modalities in the treatment of neurological disorders.
Ohkubo A; Okado T; Kurashima N; Maeda T; Miyamoto S; Nakamura A; Seshima H; Iimori S; Sohara E; Uchida S; Rai T
Ther Apher Dial; 2014 Jun; 18(3):231-7. PubMed ID: 24965288
[TBL] [Abstract][Full Text] [Related]
39. Comparing the efficacy of three techniques to reduce isoagglutinin titers in AB0 incompatible kidney transplant recipients.
Parmentier SP; Rosenkranz E; Schirutschke H; Opgenoorth M; Quick C; Hoelig K; Rosner A; Hohenstein B; Hugo C; Passauer J
Atheroscler Suppl; 2017 Nov; 30():253-256. PubMed ID: 29096846
[TBL] [Abstract][Full Text] [Related]
40. The six year experience of plasmapheresis in patients with myasthenia gravis.
Chiu HC; Chen WH; Yeh JH
Ther Apher; 2000 Aug; 4(4):291-5. PubMed ID: 10975476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
